New psoriasis drug enters first human testing
Knowledge-focused
Not yet recruiting
This early-stage study aims to see how a new version of a psoriasis drug, called CMAB015, compares to an already approved drug, Cosentyx. It will involve 114 healthy Chinese men who will receive a single injection. Researchers will track how the drugs move through the body, check…
Phase: PHASE1 • Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC